Lv7
4980 积分 2022-06-26 加入
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial
1个月前
已完结
Locally Advanced Stage IV Squamous Cell Carcinoma of the Head and Neck: Impact of Pre-Radiotherapy Hemoglobin Level and Interruptions During Radiotherapy
1个月前
已完结
The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the Literature
1个月前
已完结
Unraveling the role of discoidin domain receptors as an anti-fibrotic target in various organs: A comprehensive review
2个月前
已完结
Pirfenidone as a Pleiotropic Antifibrotic Agent in Metabolic Steatohepatitis: From Mechanisms to Clinical Evidence
2个月前
已完结
Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
2个月前
已关闭
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial
2个月前
已完结
In situ photocrosslinkable hydrogel treats radiation-induced skin injury by ROS elimination and inflammation regulation
2个月前
已完结
Radiation‐Induced Skin Injury: Mechanisms, Clinical Manifestations, and Management
2个月前
已完结
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
